Phase 3 study of ZX008 in Lennox Gastaut Syndrome

Trial Profile

Phase 3 study of ZX008 in Lennox Gastaut Syndrome

Planning
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Fenfluramine (Primary)
  • Indications Lennox-Gastaut syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2017 According to a Zogenix media release, the company expects that the first patient will enroll in the study in the fourth quarter of 2017.
    • 04 May 2017 According to a Zogenix media release, the Investigational New Drug Application has been accepted by the U.S. FDA for the commencement of this study.
    • 01 Mar 2017 According to a Zogenix media release, the company plans to initiate this study in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top